CLBK Q1 2026 Earnings EPS Misses Estimates by 178 Amid Challenging Environment OXLC Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short AVR Q1 2026 Earnings Wider Than Expected Losses as PreRevenue Biotech Advances MSGS Q1 2026 Earnings Big EPS Miss as Seasonality and Costs Weigh on Results Nexxen International Q3 2025 Earnings EPS Surges Past Estimates on Operating Efficiency BioMarin Pharmaceutical BMRN Holds Steady Near Support as Investors Evaluate Pipeline Progress Satellos Bioscience MSLE Surges 7 as Biotech Stock Breaks Above Key Support Ermenegildo Zegna ZGN Edges Lower Testing Key Support Near 1263 Onconetix Inc ONCO Edges Higher Amid Consolidation Near Key Resistance MS Q1 2026 Earnings Earnings Beat by 1092 as EPS Surges to 343